 | • レポートコード：QAF27860 • 出版社/出版日：QYResearch / 2021年4月13日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、144ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のプロカルシトニン抗体市場について種類別（ポリクローナルプロカルシトニン抗体、モノクローナルプロカルシトニン抗体）、用途別（病院、医療研究機関、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・プロカルシトニン抗体市場の概要 ・世界の主要地域別プロカルシトニン抗体市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のプロカルシトニン抗体市場規模2016-2021：種類別（ポリクローナルプロカルシトニン抗体、モノクローナルプロカルシトニン抗体） ・世界のプロカルシトニン抗体市場予測2012-2027：種類別（ポリクローナルプロカルシトニン抗体、モノクローナルプロカルシトニン抗体） ・世界のプロカルシトニン抗体市場規模2016-2021：用途別（病院、医療研究機関、その他） ・世界のプロカルシトニン抗体市場予測2012-2027：用途別（病院、医療研究機関、その他） ・プロカルシトニン抗体のアメリカ市場規模と予測2016-2021 ・プロカルシトニン抗体のヨーロッパ市場規模と予測2016-2021 ・プロカルシトニン抗体の中国市場規模と予測2016-2021 ・プロカルシトニン抗体の日本市場規模と予測2016-2021 ・プロカルシトニン抗体の東南アジア市場規模と予測2016-2021 ・プロカルシトニン抗体のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Thermo Fisher、Roche Diagnostics、bioMerieux、HyTest、Wondfo、Ningbo Medicalsystem Biotechnology、Snibe、Vazyme Biotech、Getein Biotech、Hotgen Biotech、Lumigenex、Shanghai Medicine'nest Pharmaceutical、Kitgen、Beijing KeyGen、Fantibody） ・プロカルシトニン抗体の製造コスト分析 ・販売チャネル、流通業者、顧客 ・プロカルシトニン抗体の市場動向・機会・課題 ・調査の結論 |
Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli.Procalcitonin Antibody refers to the specific protein which can qualitatively and quantitatively detect the PCT level. PCT level is a parameter for the diagnosis and monitoring of bacterial inflammatory diseases
Sepsis is a life-threatening organ dysfunction caused by an excessive host immune response to a serious infection. According to the Centers for Disease Control and Prevention (CDC), 1.6 million Americans suffered from sepsis in 2011, of which about 260,000 did not survive. PCT can play a critical role in addressing this clinical challenge and has become a key component of successful sepsis protocols across the U.S. and Europe. PCT levels increase precipitously in patients with severe bacterial infection. PCT is therefore an extremely important biomarker enabling specific differentiation between a severe bacterial infection and other causes of inflammatory reactions.
The technical barriers of procalcitonin antibody are high and the procalcitonin antibody production concentrated large companies including Thermo Fisher, Roche Diagnostics, bioMerieux, HyTest, etc. The sales revenue of top five manufacturers accounted for 37.9% in 2016. Thermo Fisher is the largest manufacturer in the world, which sales reached 2.48g in China.
The manufacture region is concentrated in South China, East China and Southwest China, of which East China is the largest region with the share 24.28% in 2016. The sales shares of Southwest China and South China were 15.59% and 14.79%.
There are companies adding new capacities and aims at the cost and quality leadership which shall improve profitability. As the same time, companies are focusing on technological innovation, equipment upgrades, and process improvements, to reduce costs and improve quality. The competition in procalcitonin antibody market will become more intense.
Market Analysis and Insights: Global Procalcitonin Antibody Market
The global Procalcitonin Antibody market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.
Global Procalcitonin Antibody Scope and Market Size
The global Procalcitonin Antibody market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Procalcitonin Antibody market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Polyclonal Procalcitonin Antibody
Monoclonal Procalcitonin Antibody
Segment by Application
Hospital
Medical research institutions
Others
The Procalcitonin Antibody market is analysed and market size information is provided by regions (countries). Segment by Application, the Procalcitonin Antibody market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Thermo Fisher
Roche Diagnostics
bioMerieux
HyTest
Wondfo
Ningbo Medicalsystem Biotechnology
Snibe
Vazyme Biotech
Getein Biotech
Hotgen Biotech
Lumigenex
Shanghai Medicine’nest Pharmaceutical
Kitgen
Beijing KeyGen
Fantibody
1 Procalcitonin Antibody Market Overview
1.1 Procalcitonin Antibody Product Scope
1.2 Procalcitonin Antibody Segment by Type
1.2.1 Global Procalcitonin Antibody Sales by Type (2016 & 2021 & 2027)
1.2.2 Polyclonal Procalcitonin Antibody
1.2.3 Monoclonal Procalcitonin Antibody
1.3 Procalcitonin Antibody Segment by Application
1.3.1 Global Procalcitonin Antibody Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospital
1.3.3 Medical research institutions
1.3.4 Others
1.4 Procalcitonin Antibody Market Estimates and Forecasts (2016-2027)
1.4.1 Global Procalcitonin Antibody Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Procalcitonin Antibody Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Procalcitonin Antibody Price Trends (2016-2027)
2 Procalcitonin Antibody Estimates and Forecasts by Region
2.1 Global Procalcitonin Antibody Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Procalcitonin Antibody Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Procalcitonin Antibody Sales Market Share by Region (2016-2021)
2.2.2 Global Procalcitonin Antibody Revenue Market Share by Region (2016-2021)
2.3 Global Procalcitonin Antibody Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Procalcitonin Antibody Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Procalcitonin Antibody Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Procalcitonin Antibody Estimates and Projections (2016-2027)
2.4.2 Europe Procalcitonin Antibody Estimates and Projections (2016-2027)
2.4.3 China Procalcitonin Antibody Estimates and Projections (2016-2027)
2.4.4 Japan Procalcitonin Antibody Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Procalcitonin Antibody Estimates and Projections (2016-2027)
2.4.6 India Procalcitonin Antibody Estimates and Projections (2016-2027)
3 Global Procalcitonin Antibody Competition Landscape by Players
3.1 Global Top Procalcitonin Antibody Players by Sales (2016-2021)
3.2 Global Top Procalcitonin Antibody Players by Revenue (2016-2021)
3.3 Global Procalcitonin Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Procalcitonin Antibody as of 2020)
3.4 Global Procalcitonin Antibody Average Price by Company (2016-2021)
3.5 Manufacturers Procalcitonin Antibody Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Procalcitonin Antibody Market Size by Type
4.1 Global Procalcitonin Antibody Historic Market Review by Type (2016-2021)
4.1.1 Global Procalcitonin Antibody Sales Market Share by Type (2016-2021)
4.1.2 Global Procalcitonin Antibody Revenue Market Share by Type (2016-2021)
4.1.3 Global Procalcitonin Antibody Price by Type (2016-2021)
4.2 Global Procalcitonin Antibody Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Procalcitonin Antibody Sales Forecast by Type (2022-2027)
4.2.2 Global Procalcitonin Antibody Revenue Forecast by Type (2022-2027)
4.2.3 Global Procalcitonin Antibody Price Forecast by Type (2022-2027)
5 Global Procalcitonin Antibody Market Size by Application
5.1 Global Procalcitonin Antibody Historic Market Review by Application (2016-2021)
5.1.1 Global Procalcitonin Antibody Sales Market Share by Application (2016-2021)
5.1.2 Global Procalcitonin Antibody Revenue Market Share by Application (2016-2021)
5.1.3 Global Procalcitonin Antibody Price by Application (2016-2021)
5.2 Global Procalcitonin Antibody Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Procalcitonin Antibody Sales Forecast by Application (2022-2027)
5.2.2 Global Procalcitonin Antibody Revenue Forecast by Application (2022-2027)
5.2.3 Global Procalcitonin Antibody Price Forecast by Application (2022-2027)
6 North America Procalcitonin Antibody Market Facts & Figures
6.1 North America Procalcitonin Antibody Sales by Company
6.1.1 North America Procalcitonin Antibody Sales by Company (2016-2021)
6.1.2 North America Procalcitonin Antibody Revenue by Company (2016-2021)
6.2 North America Procalcitonin Antibody Sales Breakdown by Type
6.2.1 North America Procalcitonin Antibody Sales Breakdown by Type (2016-2021)
6.2.2 North America Procalcitonin Antibody Sales Breakdown by Type (2022-2027)
6.3 North America Procalcitonin Antibody Sales Breakdown by Application
6.3.1 North America Procalcitonin Antibody Sales Breakdown by Application (2016-2021)
6.3.2 North America Procalcitonin Antibody Sales Breakdown by Application (2022-2027)
7 Europe Procalcitonin Antibody Market Facts & Figures
7.1 Europe Procalcitonin Antibody Sales by Company
7.1.1 Europe Procalcitonin Antibody Sales by Company (2016-2021)
7.1.2 Europe Procalcitonin Antibody Revenue by Company (2016-2021)
7.2 Europe Procalcitonin Antibody Sales Breakdown by Type
7.2.1 Europe Procalcitonin Antibody Sales Breakdown by Type (2016-2021)
7.2.2 Europe Procalcitonin Antibody Sales Breakdown by Type (2022-2027)
7.3 Europe Procalcitonin Antibody Sales Breakdown by Application
7.3.1 Europe 144 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 144 Sales Breakdown by Application (2022-2027)
8 China Procalcitonin Antibody Market Facts & Figures
8.1 China Procalcitonin Antibody Sales by Company
8.1.1 China Procalcitonin Antibody Sales by Company (2016-2021)
8.1.2 China Procalcitonin Antibody Revenue by Company (2016-2021)
8.2 China Procalcitonin Antibody Sales Breakdown by Type
8.2.1 China Procalcitonin Antibody Sales Breakdown by Type (2016-2021)
8.2.2 China Procalcitonin Antibody Sales Breakdown by Type (2022-2027)
8.3 China Procalcitonin Antibody Sales Breakdown by Application
8.3.1 China 315 Sales Breakdown by Application (2016-2021)
8.3.2 China 315 Sales Breakdown by Application (2022-2027)
9 Japan Procalcitonin Antibody Market Facts & Figures
9.1 Japan Procalcitonin Antibody Sales by Company
9.1.1 Japan Procalcitonin Antibody Sales by Company (2016-2021)
9.1.2 Japan Procalcitonin Antibody Revenue by Company (2016-2021)
9.2 Japan Procalcitonin Antibody Sales Breakdown by Type
9.2.1 Japan Procalcitonin Antibody Sales Breakdown by Type (2016-2021)
9.2.2 Japan Procalcitonin Antibody Sales Breakdown by Type (2022-2027)
9.3 Japan Procalcitonin Antibody Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Procalcitonin Antibody Market Facts & Figures
10.1 Southeast Asia Procalcitonin Antibody Sales by Company
10.1.1 Southeast Asia Procalcitonin Antibody Sales by Company (2016-2021)
10.1.2 Southeast Asia Procalcitonin Antibody Revenue by Company (2016-2021)
10.2 Southeast Asia Procalcitonin Antibody Sales Breakdown by Type
10.2.1 Southeast Asia Procalcitonin Antibody Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Procalcitonin Antibody Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Procalcitonin Antibody Sales Breakdown by Application
10.3.1 Southeast Asia mg Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia mg Sales Breakdown by Application (2022-2027)
11 India Procalcitonin Antibody Market Facts & Figures
11.1 India Procalcitonin Antibody Sales by Company
11.1.1 India Procalcitonin Antibody Sales by Company (2016-2021)
11.1.2 India Procalcitonin Antibody Revenue by Company (2016-2021)
11.2 India Procalcitonin Antibody Sales Breakdown by Type
11.2.1 India Procalcitonin Antibody Sales Breakdown by Type (2016-2021)
11.2.2 India Procalcitonin Antibody Sales Breakdown by Type (2022-2027)
11.3 India Procalcitonin Antibody Sales Breakdown by Application
11.3.1 India Procalcitonin Antibody Sales Breakdown by Application (2016-2021)
11.3.2 India Procalcitonin Antibody Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Procalcitonin Antibody Business
12.1 Thermo Fisher
12.1.1 Thermo Fisher Corporation Information
12.1.2 Thermo Fisher Business Overview
12.1.3 Thermo Fisher Procalcitonin Antibody Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Thermo Fisher Procalcitonin Antibody Products Offered
12.1.5 Thermo Fisher Recent Development
12.2 Roche Diagnostics
12.2.1 Roche Diagnostics Corporation Information
12.2.2 Roche Diagnostics Business Overview
12.2.3 Roche Diagnostics Procalcitonin Antibody Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Roche Diagnostics Procalcitonin Antibody Products Offered
12.2.5 Roche Diagnostics Recent Development
12.3 bioMerieux
12.3.1 bioMerieux Corporation Information
12.3.2 bioMerieux Business Overview
12.3.3 bioMerieux Procalcitonin Antibody Sales, Revenue and Gross Margin (2016-2021)
12.3.4 bioMerieux Procalcitonin Antibody Products Offered
12.3.5 bioMerieux Recent Development
12.4 HyTest
12.4.1 HyTest Corporation Information
12.4.2 HyTest Business Overview
12.4.3 HyTest Procalcitonin Antibody Sales, Revenue and Gross Margin (2016-2021)
12.4.4 HyTest Procalcitonin Antibody Products Offered
12.4.5 HyTest Recent Development
12.5 Wondfo
12.5.1 Wondfo Corporation Information
12.5.2 Wondfo Business Overview
12.5.3 Wondfo Procalcitonin Antibody Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Wondfo Procalcitonin Antibody Products Offered
12.5.5 Wondfo Recent Development
12.6 Ningbo Medicalsystem Biotechnology
12.6.1 Ningbo Medicalsystem Biotechnology Corporation Information
12.6.2 Ningbo Medicalsystem Biotechnology Business Overview
12.6.3 Ningbo Medicalsystem Biotechnology Procalcitonin Antibody Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Ningbo Medicalsystem Biotechnology Procalcitonin Antibody Products Offered
12.6.5 Ningbo Medicalsystem Biotechnology Recent Development
12.7 Snibe
12.7.1 Snibe Corporation Information
12.7.2 Snibe Business Overview
12.7.3 Snibe Procalcitonin Antibody Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Snibe Procalcitonin Antibody Products Offered
12.7.5 Snibe Recent Development
12.8 Vazyme Biotech
12.8.1 Vazyme Biotech Corporation Information
12.8.2 Vazyme Biotech Business Overview
12.8.3 Vazyme Biotech Procalcitonin Antibody Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Vazyme Biotech Procalcitonin Antibody Products Offered
12.8.5 Vazyme Biotech Recent Development
12.9 Getein Biotech
12.9.1 Getein Biotech Corporation Information
12.9.2 Getein Biotech Business Overview
12.9.3 Getein Biotech Procalcitonin Antibody Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Getein Biotech Procalcitonin Antibody Products Offered
12.9.5 Getein Biotech Recent Development
12.10 Hotgen Biotech
12.10.1 Hotgen Biotech Corporation Information
12.10.2 Hotgen Biotech Business Overview
12.10.3 Hotgen Biotech Procalcitonin Antibody Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Hotgen Biotech Procalcitonin Antibody Products Offered
12.10.5 Hotgen Biotech Recent Development
12.11 Lumigenex
12.11.1 Lumigenex Corporation Information
12.11.2 Lumigenex Business Overview
12.11.3 Lumigenex Procalcitonin Antibody Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Lumigenex Procalcitonin Antibody Products Offered
12.11.5 Lumigenex Recent Development
12.12 Shanghai Medicine’nest Pharmaceutical
12.12.1 Shanghai Medicine’nest Pharmaceutical Corporation Information
12.12.2 Shanghai Medicine’nest Pharmaceutical Business Overview
12.12.3 Shanghai Medicine’nest Pharmaceutical Procalcitonin Antibody Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Shanghai Medicine’nest Pharmaceutical Procalcitonin Antibody Products Offered
12.12.5 Shanghai Medicine’nest Pharmaceutical Recent Development
12.13 Kitgen
12.13.1 Kitgen Corporation Information
12.13.2 Kitgen Business Overview
12.13.3 Kitgen Procalcitonin Antibody Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Kitgen Procalcitonin Antibody Products Offered
12.13.5 Kitgen Recent Development
12.14 Beijing KeyGen
12.14.1 Beijing KeyGen Corporation Information
12.14.2 Beijing KeyGen Business Overview
12.14.3 Beijing KeyGen Procalcitonin Antibody Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Beijing KeyGen Procalcitonin Antibody Products Offered
12.14.5 Beijing KeyGen Recent Development
12.15 Fantibody
12.15.1 Fantibody Corporation Information
12.15.2 Fantibody Business Overview
12.15.3 Fantibody Procalcitonin Antibody Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Fantibody Procalcitonin Antibody Products Offered
12.15.5 Fantibody Recent Development
13 Procalcitonin Antibody Manufacturing Cost Analysis
13.1 Procalcitonin Antibody Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Procalcitonin Antibody
13.4 Procalcitonin Antibody Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Procalcitonin Antibody Distributors List
14.3 Procalcitonin Antibody Customers
15 Market Dynamics
15.1 Procalcitonin Antibody Market Trends
15.2 Procalcitonin Antibody Drivers
15.3 Procalcitonin Antibody Market Challenges
15.4 Procalcitonin Antibody Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Procalcitonin Antibody Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Procalcitonin Antibody Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Procalcitonin Antibody Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Procalcitonin Antibody Sales (mg) by Region (2016-2021)
Table 5. Global Procalcitonin Antibody Sales Market Share by Region (2016-2021)
Table 6. Global Procalcitonin Antibody Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Procalcitonin Antibody Revenue Share by Region (2016-2021)
Table 8. Global Procalcitonin Antibody Sales (mg) Forecast by Region (2022-2027)
Table 9. Global Procalcitonin Antibody Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Procalcitonin Antibody Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Procalcitonin Antibody Revenue Share Forecast by Region (2022-2027)
Table 12. Global Procalcitonin Antibody Sales (mg) of Key Companies (2016-2021)
Table 13. Global Procalcitonin Antibody Sales Share by Company (2016-2021)
Table 14. Global Procalcitonin Antibody Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Procalcitonin Antibody Revenue Share by Company (2016-2021)
Table 16. Global Procalcitonin Antibody by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Procalcitonin Antibody as of 2020)
Table 17. Global Procalcitonin Antibody Average Price (USD/mg) of Key Company (2016-2021)
Table 18. Manufacturers Procalcitonin Antibody Manufacturing Sites and Area Served
Table 19. Manufacturers Procalcitonin Antibody Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Procalcitonin Antibody Sales (mg) by Type (2016-2021)
Table 22. Global Procalcitonin Antibody Sales Share by Type (2016-2021)
Table 23. Global Procalcitonin Antibody Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Procalcitonin Antibody Price (USD/mg) by Type (2016-2021)
Table 25. Global Procalcitonin Antibody Sales Share by Type (2022-2027)
Table 26. Global Procalcitonin Antibody Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Procalcitonin Antibody Revenue Share by Type (2022-2027)
Table 28. Global Procalcitonin Antibody Price (USD/mg) by Type (2022-2027)
Table 29. Global Procalcitonin Antibody Sales (mg) by Application (2016-2021)
Table 30. Global Procalcitonin Antibody Sales Share by Application (2016-2021)
Table 31. Global Procalcitonin Antibody Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Procalcitonin Antibody Price (USD/mg) by Application (2016-2021)
Table 33. Global Procalcitonin Antibody Sales (mg) by Application (2022-2027)
Table 34. Global Procalcitonin Antibody Sales Share by Application (2022-2027)
Table 35. Global Procalcitonin Antibody Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Procalcitonin Antibody Revenue Share by Application (2022-2027)
Table 37. Global Procalcitonin Antibody Price (USD/mg) by Application (2022-2027)
Table 38. North America Procalcitonin Antibody Sales (mg) by Company (2016-2021)
Table 39. North America Procalcitonin Antibody Sales Market Share by Company (2016-2021)
Table 40. North America Procalcitonin Antibody Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Procalcitonin Antibody Revenue Market Share by Company (2016-2021)
Table 42. North America Procalcitonin Antibody Sales by Type (2016-2021) & (mg)
Table 43. North America Procalcitonin Antibody Sales Market Share by Type (2016-2021)
Table 44. North America Procalcitonin Antibody Sales by Type (2022-2027) & (mg)
Table 45. North America Procalcitonin Antibody Sales Market Share by Type (2022-2027)
Table 46. North America Procalcitonin Antibody Sales by Application (2016-2021) & (mg)
Table 47. North America Procalcitonin Antibody Sales Market Share by Application (2016-2021)
Table 48. North America Procalcitonin Antibody Sales by Application (2022-2027) & (mg)
Table 49. North America Procalcitonin Antibody Sales Market Share by Application (2022-2027)
Table 50. Europe Procalcitonin Antibody Sales (mg) by Company (2016-2021)
Table 51. Europe Procalcitonin Antibody Sales Market Share by Company (2016-2021)
Table 52. Europe Procalcitonin Antibody Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Procalcitonin Antibody Revenue Market Share by Company (2016-2021)
Table 54. Europe Procalcitonin Antibody Sales by Type (2016-2021) & (mg)
Table 55. Europe Procalcitonin Antibody Sales Market Share by Type (2016-2021)
Table 56. Europe Procalcitonin Antibody Sales by Type (2022-2027) & (mg)
Table 57. Europe Procalcitonin Antibody Sales Market Share by Type (2022-2027)
Table 58. Europe Procalcitonin Antibody Sales by Application (2016-2021) & (mg)
Table 59. Europe Procalcitonin Antibody Sales Market Share by Application (2016-2021)
Table 60. Europe Procalcitonin Antibody Sales by Application (2022-2027) & (mg)
Table 61. Europe Procalcitonin Antibody Sales Market Share by Application (2022-2027)
Table 62. China Procalcitonin Antibody Sales (mg) by Company (2016-2021)
Table 63. China Procalcitonin Antibody Sales Market Share by Company (2016-2021)
Table 64. China Procalcitonin Antibody Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Procalcitonin Antibody Revenue Market Share by Company (2016-2021)
Table 66. China Procalcitonin Antibody Sales by Type (2016-2021) & (mg)
Table 67. China Procalcitonin Antibody Sales Market Share by Type (2016-2021)
Table 68. China Procalcitonin Antibody Sales by Type (2022-2027) & (mg)
Table 69. China Procalcitonin Antibody Sales Market Share by Type (2022-2027)
Table 70. China Procalcitonin Antibody Sales by Application (2016-2021) & (mg)
Table 71. China Procalcitonin Antibody Sales Market Share by Application (2016-2021)
Table 72. China Procalcitonin Antibody Sales by Application (2022-2027) & (mg)
Table 73. China Procalcitonin Antibody Sales Market Share by Application (2022-2027)
Table 74. Japan Procalcitonin Antibody Sales (mg) by Company (2016-2021)
Table 75. Japan Procalcitonin Antibody Sales Market Share by Company (2016-2021)
Table 76. Japan Procalcitonin Antibody Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Procalcitonin Antibody Revenue Market Share by Company (2016-2021)
Table 78. Japan Procalcitonin Antibody Sales by Type (2016-2021) & (mg)
Table 79. Japan Procalcitonin Antibody Sales Market Share by Type (2016-2021)
Table 80. Japan Procalcitonin Antibody Sales by Type (2022-2027) & (mg)
Table 81. Japan Procalcitonin Antibody Sales Market Share by Type (2022-2027)
Table 82. Japan Procalcitonin Antibody Sales by Application (2016-2021) & (mg)
Table 83. Japan Procalcitonin Antibody Sales Market Share by Application (2016-2021)
Table 84. Japan Procalcitonin Antibody Sales by Application (2022-2027) & (mg)
Table 85. Japan Procalcitonin Antibody Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Procalcitonin Antibody Sales (mg) by Company (2016-2021)
Table 87. Southeast Asia Procalcitonin Antibody Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Procalcitonin Antibody Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Procalcitonin Antibody Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Procalcitonin Antibody Sales by Type (2016-2021) & (mg)
Table 91. Southeast Asia Procalcitonin Antibody Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Procalcitonin Antibody Sales by Type (2022-2027) & (mg)
Table 93. Southeast Asia Procalcitonin Antibody Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Procalcitonin Antibody Sales by Application (2016-2021) & (mg)
Table 95. Southeast Asia Procalcitonin Antibody Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Procalcitonin Antibody Sales by Application (2022-2027) & (mg)
Table 97. Southeast Asia Procalcitonin Antibody Sales Market Share by Application (2022-2027)
Table 98. India Procalcitonin Antibody Sales (mg) by Company (2016-2021)
Table 99. India Procalcitonin Antibody Sales Market Share by Company (2016-2021)
Table 100. India Procalcitonin Antibody Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Procalcitonin Antibody Revenue Market Share by Company (2016-2021)
Table 102. India Procalcitonin Antibody Sales by Type (2016-2021) & (mg)
Table 103. India Procalcitonin Antibody Sales Market Share by Type (2016-2021)
Table 104. India Procalcitonin Antibody Sales by Type (2022-2027) & (mg)
Table 105. India Procalcitonin Antibody Sales Market Share by Type (2022-2027)
Table 106. India Procalcitonin Antibody Sales by Application (2016-2021) & (mg)
Table 107. India Procalcitonin Antibody Sales Market Share by Application (2016-2021)
Table 108. India Procalcitonin Antibody Sales by Application (2022-2027) & (mg)
Table 109. India Procalcitonin Antibody Sales Market Share by Application (2022-2027)
Table 110. Thermo Fisher Corporation Information
Table 111. Thermo Fisher Description and Business Overview
Table 112. Thermo Fisher Procalcitonin Antibody Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2016-2021)
Table 113. Thermo Fisher Procalcitonin Antibody Product
Table 114. Thermo Fisher Recent Development
Table 115. Roche Diagnostics Corporation Information
Table 116. Roche Diagnostics Description and Business Overview
Table 117. Roche Diagnostics Procalcitonin Antibody Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2016-2021)
Table 118. Roche Diagnostics Procalcitonin Antibody Product
Table 119. Roche Diagnostics Recent Development
Table 120. bioMerieux Corporation Information
Table 121. bioMerieux Description and Business Overview
Table 122. bioMerieux Procalcitonin Antibody Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2016-2021)
Table 123. bioMerieux Procalcitonin Antibody Product
Table 124. bioMerieux Recent Development
Table 125. HyTest Corporation Information
Table 126. HyTest Description and Business Overview
Table 127. HyTest Procalcitonin Antibody Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2016-2021)
Table 128. HyTest Procalcitonin Antibody Product
Table 129. HyTest Recent Development
Table 130. Wondfo Corporation Information
Table 131. Wondfo Description and Business Overview
Table 132. Wondfo Procalcitonin Antibody Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2016-2021)
Table 133. Wondfo Procalcitonin Antibody Product
Table 134. Wondfo Recent Development
Table 135. Ningbo Medicalsystem Biotechnology Corporation Information
Table 136. Ningbo Medicalsystem Biotechnology Description and Business Overview
Table 137. Ningbo Medicalsystem Biotechnology Procalcitonin Antibody Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2016-2021)
Table 138. Ningbo Medicalsystem Biotechnology Procalcitonin Antibody Product
Table 139. Ningbo Medicalsystem Biotechnology Recent Development
Table 140. Snibe Corporation Information
Table 141. Snibe Description and Business Overview
Table 142. Snibe Procalcitonin Antibody Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2016-2021)
Table 143. Snibe Procalcitonin Antibody Product
Table 144. Snibe Recent Development
Table 145. Vazyme Biotech Corporation Information
Table 146. Vazyme Biotech Procalcitonin Antibody Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2016-2021)
Table 147. Vazyme Biotech Description and Business Overview
Table 148. Vazyme Biotech Procalcitonin Antibody Product
Table 149. Vazyme Biotech Recent Development
Table 150. Getein Biotech Corporation Information
Table 151. Getein Biotech Procalcitonin Antibody Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2016-2021)
Table 152. Getein Biotech Description and Business Overview
Table 153. Getein Biotech Procalcitonin Antibody Product
Table 154. Getein Biotech Recent Development
Table 155. Hotgen Biotech Corporation Information
Table 156. Hotgen Biotech Description and Business Overview
Table 157. Hotgen Biotech Procalcitonin Antibody Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2016-2021)
Table 158. Hotgen Biotech Procalcitonin Antibody Product
Table 159. Hotgen Biotech Recent Development
Table 160. Lumigenex Corporation Information
Table 161. Lumigenex Description and Business Overview
Table 162. Lumigenex Procalcitonin Antibody Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2016-2021)
Table 163. Lumigenex Procalcitonin Antibody Product
Table 164. Lumigenex Recent Development
Table 165. Shanghai Medicine'nest Pharmaceutical Corporation Information
Table 166. Shanghai Medicine'nest Pharmaceutical Description and Business Overview
Table 167. Shanghai Medicine'nest Pharmaceutical Procalcitonin Antibody Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2016-2021)
Table 168. Shanghai Medicine'nest Pharmaceutical Procalcitonin Antibody Product
Table 169. Shanghai Medicine'nest Pharmaceutical Recent Development
Table 170. Kitgen Corporation Information
Table 171. Kitgen Description and Business Overview
Table 172. Kitgen Procalcitonin Antibody Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2016-2021)
Table 173. Kitgen Procalcitonin Antibody Product
Table 174. Kitgen Recent Development
Table 175. Beijing KeyGen Corporation Information
Table 176. Beijing KeyGen Description and Business Overview
Table 177. Beijing KeyGen Procalcitonin Antibody Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2016-2021)
Table 178. Beijing KeyGen Procalcitonin Antibody Product
Table 179. Beijing KeyGen Recent Development
Table 180. Fantibody Corporation Information
Table 181. Fantibody Description and Business Overview
Table 182. Fantibody Procalcitonin Antibody Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2016-2021)
Table 183. Fantibody Procalcitonin Antibody Product
Table 184. Fantibody Recent Development
Table 185. Production Base and Market Concentration Rate of Raw Material
Table 186. Key Suppliers of Raw Materials
Table 187. Procalcitonin Antibody Distributors List
Table 188. Procalcitonin Antibody Customers List
Table 189. Procalcitonin Antibody Market Trends
Table 190. Procalcitonin Antibody Market Drivers
Table 191. Procalcitonin Antibody Market Challenges
Table 192. Procalcitonin Antibody Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Procalcitonin Antibody Product Picture
Figure 2. Global Procalcitonin Antibody Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Procalcitonin Antibody Sales Market Share by Application in 2021 & 2027
Figure 6. Hospital Examples
Figure 7. Medical research institutions Examples
Figure 8. Others Examples
Figure 9. Global Procalcitonin Antibody Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Procalcitonin Antibody Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Procalcitonin Antibody Sales (mg) Growth Rate (2016-2027)
Figure 12. Global Procalcitonin Antibody Price Trends Growth Rate (2016-2027) (USD/mg)
Figure 13. Global Procalcitonin Antibody Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Procalcitonin Antibody Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Procalcitonin Antibody Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Procalcitonin Antibody Sales (mg) Growth Rate (2016-2027)
Figure 17. Europe Procalcitonin Antibody Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Procalcitonin Antibody Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Procalcitonin Antibody Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Procalcitonin Antibody Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Procalcitonin Antibody Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Procalcitonin Antibody Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Procalcitonin Antibody Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Procalcitonin Antibody Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Procalcitonin Antibody Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Procalcitonin Antibody Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Procalcitonin Antibody Players Market Share by Revenue in Procalcitonin Antibody: 2016 & 2020
Figure 28. Procalcitonin Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Procalcitonin Antibody Revenue Share by Type (2016-2021)
Figure 30. Global Procalcitonin Antibody Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Procalcitonin Antibody Revenue Share by Application (2016-2021)
Figure 32. Global Procalcitonin Antibody Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Procalcitonin Antibody Sales Market Share by Type in 2020
Figure 34. North America Procalcitonin Antibody Sales Market Share by Application in 2020
Figure 35. Europe Procalcitonin Antibody Sales Market Share by Type in 2020
Figure 36. Europe Procalcitonin Antibody Sales Market Share by Application in 2020
Figure 37. China Procalcitonin Antibody Sales Market Share by Type in 2020
Figure 38. China Procalcitonin Antibody Sales Market Share by Application in 2020
Figure 39. Japan Procalcitonin Antibody Sales Market Share by Type in 2020
Figure 40. Japan Procalcitonin Antibody Sales Market Share by Application in 2020
Figure 41. Southeast Asia Procalcitonin Antibody Sales Market Share by Type in 2020
Figure 42. Southeast Asia Procalcitonin Antibody Sales Market Share by Application in 2020
Figure 43. India Procalcitonin Antibody Sales Market Share by Type in 2020
Figure 44. India Procalcitonin Antibody Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Procalcitonin Antibody
Figure 47. Manufacturing Process Analysis of Procalcitonin Antibody
Figure 48. Procalcitonin Antibody Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
プロカルシトニン迅速検査キットのグローバル市場調査 2019年 The global Procalcitonin Rapid Test Kit market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Procalcitonin Rapid Test Kit volume and value at global level, regional level and company level. From a global…- プロカルシトニン迅速検査キットのグローバル市場調査 2019年 The global Procalcitonin Rapid Test Kit market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Procalcitonin Rapid Test Kit volume and value at global level, regional level and company level. From a global…
- 世界の狂犬病モノクローナル抗体市場規模・現状・予測（2021年-2027年） Anti-rabies virus monoclonal antibody is a passive immune preparation, which has the same or better neutralizing effect as rabies immunoglobulin. The development of anti-rabies virus monoclonal antibodies to replace traditional human immunoglobulin and immune antiserum products is an important direc…
- モノクローナル抗体診断試薬のグローバル市場2021 Monoclonal Antibody Diagnostic Reagents are reagents whose active ingredients are monoclonal antibodies to identify infectious agents, abnormal cells or elements of the body's response to disease. At present, in the foreign industrial developed countries the Monoclonal Antibody Diagnostic Reagents i…
- 世界のウサギ抽出抗DPH5抗体市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-DPH5 Antibody Produced In Rabbit Market The global Anti-DPH5 Antibody Produced In Rabbit market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and…